Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study
Pol S, Thompson A, Collins M, Venier E, Cotte L, Laguno Centeno M, et al. Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study. Hepatology, May 20, 2024. | DOI: 10.1097/HEP.0000000000000923 Πατώντας ΕΔΩ μπορείτε να δείτε την περίληψη του άρθρου
Λεπτομέρειες